whats the half life of retatrutide what is Retatrutide UK 2026: Phase 3 Results Retatrutide (12mg Vial) Dosage Protocol

Ozempic and the Risk of nAMD A recent article in JAMA Ophthamology (June 2025) suggests that vascular changes triggered by GLP-1 activity may trigger or worsen nAMD in some patients, especially those who are older, diabetic, or already at risk for macular degeneration

As more GLP-1 drugs become available, including the newly approved pill Foundayo, and more people take them over longer periods, researchers may get a clearer picture of whether the medications affect cancer risk

Activity recording is turned off

How doctors of optometry can help While GLP-1RAs can significantly improve cardiovascular and diabetes symptoms, patients with preexisting ocular disease might be at increased risk

RESET YOUR WEIGHT

Early research suggests that GLP-1 medications may affect how the skin maintains collagen and elastin the proteins that give skin strength and elasticity